50 related articles for article (PubMed ID: 32688220)
41. Management of patients with acute promyelocytic leukemia.
Kayser S; Schlenk RF; Platzbecker U
Leukemia; 2018 Jun; 32(6):1277-1294. PubMed ID: 29743722
[TBL] [Abstract][Full Text] [Related]
42. The success and the challenge of all-trans retinoic acid in the treatment of cancer.
Ni X; Hu G; Cai X
Crit Rev Food Sci Nutr; 2019; 59(sup1):S71-S80. PubMed ID: 30277803
[TBL] [Abstract][Full Text] [Related]
43. Arsenic trioxide as a novel anti-glioma drug: a review.
Fang Y; Zhang Z
Cell Mol Biol Lett; 2020; 25():44. PubMed ID: 32983240
[TBL] [Abstract][Full Text] [Related]
44. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Sanz MA; Fenaux P; Tallman MS; Estey EH; Löwenberg B; Naoe T; Lengfelder E; Döhner H; Burnett AK; Chen SJ; Mathews V; Iland H; Rego E; Kantarjian H; Adès L; Avvisati G; Montesinos P; Platzbecker U; Ravandi F; Russell NH; Lo-Coco F
Blood; 2019 Apr; 133(15):1630-1643. PubMed ID: 30803991
[TBL] [Abstract][Full Text] [Related]
45. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors.
Sönksen M; Kerl K; Bunzen H
Med Res Rev; 2022 Jan; 42(1):374-398. PubMed ID: 34309879
[TBL] [Abstract][Full Text] [Related]
46. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
[No Abstract] [Full Text] [Related]
47. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
[TBL] [Abstract][Full Text] [Related]
48. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
[TBL] [Abstract][Full Text] [Related]
49. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
Breccia M; Foà R
Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
[TBL] [Abstract][Full Text] [Related]
50. [A neonate born to a mother with acute promyelocytic leukemia treated by all-trans retinoic acid].
Maeda M; Tyugu H; Okubo T; Yamamoto M; Nakamura K; Dan K
Rinsho Ketsueki; 1997 Sep; 38(9):770-5. PubMed ID: 9364869
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]